Dr. Raimy Amasha, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,738 | 911 | 50.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,490 | 13 | 33.6% |
| Travel and Lodging | $4,691 | 21 | 9.6% |
| Consulting Fee | $2,250 | 1 | 4.6% |
| Education | $891.70 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pernix Therapeutics Holdings, Inc. | $15,699 | 35 | $0 (2018) |
| Abbott Laboratories | $9,117 | 250 | $0 (2024) |
| PFIZER INC. | $3,606 | 66 | $0 (2024) |
| Boston Scientific Corporation | $3,307 | 62 | $0 (2024) |
| Lilly USA, LLC | $2,277 | 3 | $0 (2020) |
| Spinal Simplicity, LLC | $2,114 | 7 | $0 (2024) |
| Nevro Corp. | $1,648 | 47 | $0 (2022) |
| Vertiflex, Inc. | $1,400 | 18 | $0 (2019) |
| ABBVIE INC. | $775.78 | 34 | $0 (2024) |
| Medinc of Texas | $764.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,172 | 67 | Abbott Laboratories ($1,412) |
| 2023 | $2,836 | 88 | Abbott Laboratories ($1,359) |
| 2022 | $3,323 | 107 | Abbott Laboratories ($1,945) |
| 2021 | $6,328 | 154 | Spinal Simplicity, LLC ($2,082) |
| 2020 | $4,557 | 91 | Lilly USA, LLC ($2,250) |
| 2019 | $4,835 | 143 | Abbott Laboratories ($1,278) |
| 2018 | $19,177 | 169 | Pernix Therapeutics Holdings, Inc. ($14,366) |
| 2017 | $5,833 | 130 | PFIZER INC. ($2,836) |
All Payment Transactions
949 individual payment records from CMS Open Payments — Page 3 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/22/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 02/22/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Analgesic | ||||||
| 02/14/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $149.28 | General |
| Category: Neuromodulation | ||||||
| 02/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Neuromodulation | ||||||
| 02/02/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: Neuromodulation | ||||||
| 01/31/2024 | Bioventus LLC | DUROLANE (Device) | Food and Beverage | In-kind items and services | $35.52 | General |
| Category: ORTHOPEDICSORTHOPEDIC SURGERY | ||||||
| 01/25/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: NEUROSCIENCE | ||||||
| 01/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: Neuromodulation | ||||||
| 01/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: Neuromodulation | ||||||
| 01/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: Neuromodulation | ||||||
| 01/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: Neuromodulation | ||||||
| 01/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: Neuromodulation | ||||||
| 01/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Gastroenterology | ||||||
| 01/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: PAIN | ||||||
| 12/29/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $132.55 | General |
| Category: Neuromodulation | ||||||
| 12/29/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Neuromodulation | ||||||
| 12/29/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: Neuromodulation | ||||||
| 12/28/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: Neuromodulation | ||||||
| 12/21/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: Neuromodulation | ||||||
| 12/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Gastroenterology | ||||||
| 12/19/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Gastroenterology | ||||||
| 12/14/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,665 | 4,143 | $3.5M | $470,982 |
| 2022 | 24 | 2,248 | 3,915 | $3.0M | $384,775 |
| 2021 | 25 | 2,289 | 4,648 | $3.1M | $412,894 |
| 2020 | 27 | 3,308 | 7,106 | $4.2M | $509,596 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 385 | 462 | $600,600 | $110,711 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 371 | 1,040 | $795,631 | $99,269 | 12.5% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 264 | 402 | $522,600 | $78,298 | 15.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 699 | 969 | $581,400 | $58,464 | 10.1% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 191 | 242 | $314,600 | $37,137 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 210 | 346 | $178,189 | $22,464 | 12.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 82 | 106 | $85,582 | $10,153 | 11.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 35 | 42 | $67,153 | $8,586 | 12.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 84 | 84 | $64,233 | $7,320 | 11.4% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 13 | 25 | $73,974 | $6,143 | 8.3% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 21 | 24 | $38,905 | $4,976 | 12.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 25 | 42 | $27,380 | $4,016 | 14.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 42 | 52 | $31,271 | $3,915 | 12.5% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 15 | 27 | $20,559 | $2,850 | 13.9% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 28 | 34 | $24,231 | $2,638 | 10.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 34 | 41 | $17,533 | $2,549 | 14.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 25 | 42 | $15,835 | $2,258 | 14.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $19,799 | $2,159 | 10.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 39 | 47 | $17,509 | $1,883 | 10.8% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 20 | 23 | $11,264 | $1,645 | 14.6% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 13 | 23 | $10,056 | $1,319 | 13.1% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 15 | 15 | $19,500 | $1,071 | 5.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 12 | 13 | $5,576 | $512.43 | 9.2% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Facility | 2023 | 11 | 11 | $3,261 | $347.38 | 10.7% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 14 | 14 | $2,803 | $297.78 | 10.6% |
About Dr. Raimy Amasha, MD
Dr. Raimy Amasha, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1760643498.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raimy Amasha, MD has received a total of $49,061 in payments from pharmaceutical and medical device companies, with $2,172 received in 2024. These payments were reported across 949 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($24,738).
As a Medicare-enrolled provider, Amasha has provided services to 10,510 Medicare beneficiaries, totaling 19,812 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Student in an Organized Health Care Education/Training Program, Pain Medicine
- Location Austin, TX
- Active Since 06/25/2008
- Last Updated 11/26/2025
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1760643498
Products in Payments
- SILENOR (Drug) $10,561
- ZOHYDRO ER (Drug) $5,138
- PROCLAIM (Device) $4,553
- EMBEDA (Drug) $2,737
- Proclaim Family of SCS IPGs (Device) $2,527
- HA MINUTEMAN G3-R (Device) $2,114
- SPECTRA WAVEWRITER (Device) $1,750
- Superion ISS (Device) $1,400
- Proclaim IPG (Device) $1,286
- Senza II (Device) $1,009
- NURTEC ODT (Drug) $710.74
- Intracept (Device) $548.79
- Senza Spinal Cord Stimulation System (Device) $477.99
- SCS IPGs (Device) $461.74
- Morphabond ER (Drug) $427.58
- Horizant (Drug) $398.14
- UBRELVY (Drug) $364.66
- RELISTOR (Drug) $364.58
- Superion (Device) $351.56
- XTAMPZA (Drug) $350.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Austin
Dr. Jose Romero, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $42,986
Erik Krause, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $27,736
Dr. Gregory Catlett, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $24,455
Sara Pavitt
Student in an Organized Health Care Education/Training Program — Payments: $23,230
Dr. Elizabeth Foley, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $17,688
Katherine Smith, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $15,453